Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNECTICS PLC Director's Dealing 2023

Oct 11, 2023

7942_dirs_2023-10-11_5fffa07d-4596-462c-b396-04114d939114.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6849P

Synectics PLC

11 October 2023

RNS

11 October 2023

Synectics plc

("Synectics" or the "Company")

Director/PDMR dealings

Synectics plc (AIM: SNX), a leader in advanced security and surveillance systems, has been notified that on 9 and 10 October 2023, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 13,814 (3,955 and 9,859 respectively) ordinary shares of 20 pence each in the Company ("Ordinary Shares") at an average price of £1.22137 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2023.

Under the terms of the ESAP, participating members, including employees, an Executive Director of the Company and a PDMR, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Ordinary Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per Ordinary Share at the beginning of the Period which was £1.15.

As a result of this purchase, the Company has been notified that the following Executive Director and a PDMR have acquired the following interests in Ordinary Shares:

Name Position Status Number of Ordinary Shares purchased by the Trustee
Paul Webb Chief Executive Executive Director 782
David Gavin Divisional Director PDMR 782

Following these purchases, the interests of Messrs Webb and Gavin in the Ordinary Shares are as follows:

Name Number of Ordinary Shares Held Interest in Ordinary Shares in Share Schemes Resultant Total Interest % of Issued Share Capital
Paul Webb 57,115 515,079 572,194 3.22
David Gavin 0 60,782 60,782 0.34

For further information, please contact:

Synectics plc

Claire Stewart, Company Secretary

email: [email protected]
Tel: +44 (0) 114 280 2828

www.synecticsplc.com
Shore Capital

Tom Griffiths / David Coaten
Tel: +44 (0) 20 7408 4090
Vigo Consulting

Jeremy Garcia / Fiona Hetherington

[email protected]
Tel: +44 (0) 20 7390 0230

About Synectics

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance systems that help protect people, property, communities, and assets around the world.

The Company's expertise is in providing solutions for specific markets where security and surveillance are critical to operations. These include gaming, oil and gas, public space, transportation, and critical infrastructure.

Synectics has deep industry experience in these markets and works closely with customers to deliver solutions that are tailored to meet their needs. Technical excellence, combined with decades of experience and long-standing customer relationships, provides fundamental differentiation from mainstream suppliers and makes the Company a stand out in its field.

Find out more at www.synecticsplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQBLFFXBLBFBL